The perfusionist Armel Kinda, the specialist responsible for the machinery that breathes for a patient during surgery, recognized that the high cost of imported cardioplegia solutions was an invisible barrier to care. To mend a heart, one must first convince it to stop beating without causing it permanent harm. Kinda and his collaborators looked to the established international formula developed by Dr. Pedro J. del Nido, realizing that the essential components could be compounded with clinical precision within their own hospital walls.
A single clear vial of this locally mixed "Solution de Tengandogo," resting on a stainless steel tray, holds the power to pause a life so that it may be saved. By combining specific salts with lidocaine—the same common anesthetic used in dentistry—the team created a solution that provides the surgeon with 90 minutes of uninterrupted time to repair valves or vessels. This single-dose method eliminates the need to repeatedly interrupt the procedure, a technical advantage that is as much about patient safety as it is about efficiency.
The significance of this work was formally recognized when Dr. Adama Sawadogo presented the clinical results before a jury of distinguished professors, including Amadou Gabriel Ciss. The data showed that the local solution was not merely a substitute, but a rigorous scientific success. Of the 157 patients operated on between 2021 and 2024, the vast majority were successfully treated using the more affordable mixture.
This achievement represents a reclamation of the operating room from the pressures of global logistics and high-interest medical commerce. By producing their own life-saving chemistry, the clinicians in Burkina Faso have ensured that the rhythm of a patient’s future is no longer dictated by the price of an imported vial. It is a victory of local expertise over structural scarcity, proving that the most complex medicine can be practiced with dignity when human ingenuity is allowed to lead.